Methenolone Enanthate (Primobolan) 100 mg

Methenolone Enanthate (Primobolan) 100 mg is Hilma Biocare's injectable Primobolan, supplied as a 10 ml vial at 100 mg/ml. Methenolone is a mild, non-aromatising dihydrotestosterone derivative, and the enanthate ester gives it a slow, steady release suited to long, gradual research protocols.

What Methenolone Enanthate Is

Methenolone is an anabolic androgenic steroid built on a dihydrotestosterone backbone with a double bond at carbon one and a methyl group at carbon two. Those modifications make it resistant to metabolism and unable to aromatise, which is why it is regarded as one of the mildest injectable androgens. The enanthate ester at the 17-beta position slows absorption from the injection site, producing a depot that sustains levels for roughly one to two weeks. Primobolan Depot, as the enanthate is known, is the injectable counterpart to the oral acetate.

The History of Primobolan

Methenolone was developed by Schering in the late 1950s and introduced in the early 1960s as Primobolan. It was used clinically in Europe for conditions involving muscle wasting, osteoporosis and, in some cases, as an adjunct in breast cancer. The oral acetate and injectable enanthate were both marketed, and the injectable became known for its gentle profile. Primobolan also acquired a reputation as one of the most counterfeited steroids in the world, which is why sealed, code-verified packaging matters so much today.

How It Works

Esterases hydrolyse the enanthate chain slowly after intramuscular injection, releasing free methenolone into circulation over an extended period. Methenolone binds the androgen receptor and supports nitrogen retention and protein synthesis, but it is not aromatised and has minimal oestrogenic activity. It is metabolised in the liver and excreted in urine, partly as unchanged compound. The slow ester creates stable blood levels, which is the main reason the injectable is preferred over the acetate for longer research windows.

What the Research Shows

• Methenolone was investigated clinically in Europe in the 1960s and 1970s for wasting and osteoporosis.
• Its low aromatisation and mild androgenic profile are documented in comparative steroid pharmacology.
• Enanthate esters are well characterised for producing prolonged, stable release compared with acetate.
• Primobolan's counterfeit prevalence has made analytical verification a recurring research topic.

Research Context

Methenolone's clinical history includes use in women and children, which is unusual for an anabolic steroid and reflects its mild androgenic profile. European studies in the 1960s and 1970s examined it in osteoporosis and wasting, and later research in East Germany documented its use in female athletes. Analytical chemists have identified long-lived metabolites that allow detection weeks after administration. The combination of mild effects and a long detection window is a recurring theme in the methenolone literature.

Strength, Pack and Authentication

Each vial contains 100 mg of methenolone enanthate per millilitre, for 1000 mg total in 10 ml. It is filled under controlled conditions, sealed with a colour-coded flip-off cap and packed in a printed carton stating the compound, strength and volume. A scratch-off security code inside the box links the pack to Hilma Biocare's records.

Buying Primobolan Online

Primobolan is one of the most searched injectables in the world. If you are researching methenolone enanthate, comparing primobolan 100 products or looking to buy primobolan online from a trusted Hilma Biocare supplier, this page gives you the complete specification, pack size, price and live stock status. Browse more Hilma Biocare injectables at NotNatty.